Which of the following is a common adverse drug reaction associated with Benazepril Hydrochloride?

Which of the following is a common adverse drug reaction associated with Benazepril Hydrochloride?

• A. Headache
• B. Dry cough
• C. Nausea
• D. Rash

Answer: (B)

Benazepril Hydrochloride is an angiotensin-converting enzyme (ACE) inhibitor commonly used to treat hypertension and heart failure. One of the well-documented adverse drug reactions associated with ACE inhibitors, including Benazepril, is a dry cough. This side effect occurs due to the accumulation of bradykinin and substance P, both of which are normally broken down by the angiotensin-converting enzyme. When this enzyme is inhibited, as it is with Benazepril, these substances can accumulate and lead to coughing. While headache, nausea, and rash can occur as side effects of various medications, they are not as characteristic or common in patients taking Benazepril compared to the dry cough. The prevalence and specific mechanism of the dry cough make it a notable reaction, which is why choosing it as the answer highlights a key aspect of understanding the pharmacological profile of ACE inhibitors.

Benazepril Hydrochloride is an angiotensin-converting enzyme (ACE) inhibitor commonly used to treat hypertension and heart failure. One of the well-documented adverse drug reactions associated with ACE inhibitors, including Benazepril, is a dry cough. This side effect occurs due to the accumulation of bradykinin and substance P, both of which are normally broken down by the angiotensin-converting enzyme. When this enzyme is inhibited, as it is with Benazepril, these substances can accumulate and lead to coughing.

While headache, nausea, and rash can occur as side effects of various medications, they are not as characteristic or common in patients taking Benazepril compared to the dry cough. The prevalence and specific mechanism of the dry cough make it a notable reaction, which is why choosing it as the answer highlights a key aspect of understanding the pharmacological profile of ACE inhibitors.